Geode Capital Management
AMED

Geode Capital Management’s Amedisys AMED Stock Holding History

Geode Capital Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-611,333
Closed -$60.2M – 4477
2025
Q2 		$60.2M Buy
611,333
+11,474
+2% +$1.09M ﹤0.01% 1324
2025
Q1 		$55.6M Buy
599,859
+26,839
+5% +$2.47M ﹤0.01% 1320
2024
Q4 		$52M Buy
573,020
+5,915
+1% +$543K ﹤0.01% 1409
2024
Q3 		$54.7M Buy
567,105
+7,071
+1% +$690K ﹤0.01% 1371
2024
Q2 		$51.4M Buy
560,034
+9,960
+2% +$924K ﹤0.01% 1346
2024
Q1 		$50.7M Buy
550,074
+22,526
+4% +$2.11M ﹤0.01% 1347
2023
Q4 		$50.2M Buy
527,548
+13,832
+3% +$1.29M 0.01% 1338
2023
Q3 		$48M Buy
513,716
+8,429
+2% +$779K 0.01% 1255
2023
Q2 		$46.2M Buy
505,287
+20,701
+4% +$1.7M 0.01% 1310
2023
Q1 		$35.6M Buy
484,586
+15,231
+3% +$1.32M ﹤0.01% 1424
2022
Q4 		$39.2M Buy
469,355
+22,394
+5% +$2.02M 0.01% 1325
2022
Q3 		$43.3M Buy
446,961
+6,667
+2% +$795K 0.01% 1177
2022
Q2 		$46.3M Buy
440,294
+4,563
+1% +$583K 0.01% 1187
2022
Q1 		$75.1M Buy
435,731
+14,561
+3% +$2.18M 0.01% 948
2021
Q4 		$68.2M Sell
421,170
-1,460
-0.3% -$235K 0.01% 1068
2021
Q3 		$63M Sell
422,630
-48,622
-10% -$10.1M 0.01% 1083
2021
Q2 		$115M Buy
471,252
+29,577
+7% +$7.76M 0.02% 718
2021
Q1 		$117M Buy
441,675
+22,383
+5% +$6.31M 0.02% 680
2020
Q4 		$123M Buy
419,292
+39,948
+11% +$10.2M 0.02% 614
2020
Q3 		$89.7M Sell
379,344
-11,731
-3% -$2.67M 0.02% 647
2020
Q2 		$77.6M Sell
391,075
-108,537
-22% -$20.2M 0.02% 661
2020
Q1 		$91.7M Buy
499,612
+29,835
+6% +$5.31M 0.02% 529
2019
Q4 		$78.4M Buy
469,777
+17,435
+4% +$2.59M 0.02% 709
2019
Q3 		$59.3M Buy
452,342
+26,010
+6% +$3.39M 0.01% 798
2019
Q2 		$51.8M Sell
426,332
-18,617
-4% -$2.21M 0.01% 848
2019
Q1 		$54.8M Buy
444,949
+14,950
+3% +$1.88M 0.01% 788
2018
Q4 		$50.4M Buy
429,999
+81,573
+23% +$9.61M 0.02% 728
2018
Q3 		$43.5M Buy
348,426
+58,316
+20% +$6.44M 0.01% 872
2018
Q2 		$24.8M Buy
290,110
+17,556
+6% +$1.29M 0.01% 1201
2018
Q1 		$16.4M Sell
272,554
-2,438
-0.9% -$139K 0.01% 1396
2017
Q4 		$14.5M Sell
274,992
-11,780
-4% -$621K ﹤0.01% 1494
2017
Q3 		$16M Buy
286,772
+45,237
+19% +$2.39M 0.01% 1408
2017
Q2 		$15.2M Buy
241,535
+9,582
+4% +$558K 0.01% 1401
2017
Q1 		$11.8M Buy
231,953
+7,279
+3% +$347K ﹤0.01% 1496
2016
Q4 		$9.58M Buy
224,674
+16,789
+8% +$714K ﹤0.01% 1610
2016
Q3 		$9.86M Buy
207,885
+764
+0.4% +$38.1K 0.01% 1504
2016
Q2 		$10.5M Buy
207,121
+1,774
+0.9% +$89.5K 0.01% 1400
2016
Q1 		$9.93K Buy
205,347
+9,523
+5% +$367K 0.01% 1406
2015
Q4 		$7.7M Sell
195,824
-21,247
-10% -$850K ﹤0.01% 1564
2015
Q3 		$8.24M Buy
217,071
+6,039
+3% +$255K 0.01% 1476
2015
Q2 		$8.38M Buy
211,032
+7,664
+4% +$239K ﹤0.01% 1539
2015
Q1 		$5.45M Buy
203,368
+16,838
+9% +$475K ﹤0.01% 1813
2014
Q4 		$5.47M Buy
186,530
+2,630
+1% +$64.9K ﹤0.01% 1759
2014
Q3 		$3.71M Buy
183,900
+10,309
+6% +$199K ﹤0.01% 1948
2014
Q2 		$2.9M Sell
173,591
-1,056
-0.6% -$15K ﹤0.01% 2155
2014
Q1 		$2.6M Buy
174,647
+17,546
+11% +$270K ﹤0.01% 2184
2013
Q4 		$2.3M Buy
157,101
+17,192
+12% +$277K ﹤0.01% 2214
2013
Q3 		$2.41M Buy
139,909
+4,286
+3% +$63.6K ﹤0.01% 2057
2013
Q2 		$1.58M Buy
+135,623
New +$1.55M ﹤0.01% 2183

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Geode Capital Management's AMED Position: Q3 2025 in Review

Geode Capital Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 611,333 shares — an estimated $60.2M sold.

Geode Capital Management first reported a position in AMED in Q2 2013 and held it in 49 quarters. The position peaked at $123M in Q4 2020. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Geode Capital Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Geode Capital Management sold 611,333 Amedisys shares in Q3 2025, an estimated $60.2M.
  • Geode Capital Management first reported a position in Amedisys in Q2 2013 and held it in 49 quarters.
  • Geode Capital Management's Amedisys position peaked at $123M in Q4 2020.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Geode Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.